Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Photobiomodulation of the Ocular Surface and Eyelids With Different Wavelengths: REd vs BluE Light (REBEL)

NCT06371300 is registered in ClinicalTrials.gov with Aston University as lead sponsor.

NCT NCT06371300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06371300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Photobiomodulation of the Ocular Surface and Eyelids With Different Wavelengths: REd vs BluE Light (REBEL)
Lead sponsor
Aston University
Phase
Not applicable
Overall status
Recruiting
Start date
May 1, 2024
Completion date
December 30, 2026
Enrollment
36 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

blepharitis, dry eye syndromes, meibomian gland dysfunction